Changes in lipid and carbohydrate metabolism and in body composition associated with the most potent and effective therapies available are being reported with increasing frequency. These changes could potentially lead to increased risks of cardiovascular disease. Clinical trials set up to investigate new antiretroviral therapies need to explore the therapies' impact on these potentially serious adverse outcomes, at least in a subset of patients. The measurements that are feasible to include f...Expand abstract
- Publisher copy:
- Copyright date:
The evaluation of metabolic function and fat redistribution in clinical trials.
If you are the owner of this record, you can report an update to it here: Report update to this record